Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00913809 | To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets | PHASE1 | COMPLETED | 36 | — | — | Dec 1, 1987 | Dec 1, 1987 | Mar 28, 2017 | - | — |
| NCT00914004 | To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin Tablets | PHASE1 | COMPLETED | 36 | — | — | - | - | Mar 28, 2017 | - | — |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Desipramine HCL 100 mg Tablets Cord Laboratories |
| 2 | ACTIVE_COMPARATOR | Norpramin 100 mg Tablets Merrell Dow Pharmaceuticals, Inc |
| Name | Type | Description |
|---|---|---|
| Desipramine HCL 100 mg Tablets Cord Laboratories | DRUG | - |
| Norpramin 100 mg Tablets Merrell Dow Pharmaceuticals, Inc | DRUG | - |
| Desipramine HCl 50 mg Tablets Cord Laboratories | DRUG | - |
| Norpramin 50 mg Tablets Merrell Dow Pharmaceuticals, Inc | DRUG | - |
Inclusion Criteria: * No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Exclusion Criteria: * Positive test results for HIV or hepatitis B or C. * Treatment for drug or alcohol dependence.